Literature DB >> 29991561

Surgical Treatment for Encapsulating Peritoneal Sclerosis: 24 Years' Experience.

Hideki Kawanishi1,2, Masataka Banshodani3, Masahiro Yamashita3, Sadanori Shintaku3, Kiyohiko Dohi3,2.   

Abstract

BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is a serious complication of long-term peritoneal dialysis. The mortality rate for EPS is high, primarily due to complications related to bowel obstruction. Surgery was previously contraindicated; however, surgical enterolysis is performed for patients in whom bowel obstruction fails to improve.
METHODS: This was a retrospective observational study of patients with EPS who received surgical intervention at a single center between November 1993 and October 2017. The severity of intestine damage was characterized by grade-3 peritoneal calcification on abdominal computed tomography (CT) scan and degeneration of the small intestinal wall in surgery.
RESULTS: Two-hundred and forty-three patients with EPS opted for surgery. Among them, 58 had recurrence and required re-surgery; a total of 318 EPS surgeries were performed. Death was related to EPS in 61 patients (25.1%), of whom 15 died postoperatively. Sixty-seven patients (27.6%) died from other causes. The actuarial survival rates at 1, 2, 3, 5, and 8 years after EPS diagnosis were 91%, 83%, 77%, 66%, and 53% respectively. The 50% actuarial survival points after EPS diagnosis and surgery were 104 months and 85 months, respectively. Peritoneal calcification and small intestinal wall degeneration grading showed significant association with the mortality curve for EPS-related death.
CONCLUSION: Excellent outcomes for EPS are achieved with surgery. The degree of peritoneal deterioration affected the clinical outcomes. Currently, EPS is no longer recognized as a fatal complication.
Copyright © 2019 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  EPS; surgery

Mesh:

Year:  2018        PMID: 29991561     DOI: 10.3747/pdi.2018.00042

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

1.  Outcomes of the surgical management of encapsulating peritoneal sclerosis: A case series from a single center in Korea.

Authors:  Jung-Hwa Ryu; Kil-Yong Lee; Tai Yeon Koo; Dong Ki Kim; Kook-Hwan Oh; Jaeseok Yang; Kyu Joo Park
Journal:  Kidney Res Clin Pract       Date:  2019-12-31

Review 2.  Surgical management of Encapsulating Peritoneal Sclerosis (EPS) in children: international case series and literature review.

Authors:  Videha Sharma; Zia Moinuddin; Angela Summers; Mohan Shenoy; Nicholas Plant; Semir Vranic; Agnieszka Prytula; Zlatan Zvizdic; Vasiliki Karava; Nikoleta Printza; John Vlot; David van Dellen; Titus Augustine
Journal:  Pediatr Nephrol       Date:  2021-08-26       Impact factor: 3.714

Review 3.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

4.  Liver cirrhosis with encapsulating peritoneal sclerosis after 4 years of peritoneal dialysis: A case report.

Authors:  Kanako Watanabe-Kusunoki; Yoshihiro Kusunoki; Junichi Goto; Kazutaka Kukita
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.